When something is working extremely well, we should demand very compelling evidence before changing it. I believe that’s why ...
Johnson & Johnson is set to push for confirmation of a bankruptcy plan next week that would settle a vast majority of cases ...
Eli Lilly shares first human trial results for LOXO-435, a selective FGFR3 inhibitor for bladder cancer, showing 41% response ...
GSK has snagged FDA approval for its 5-in-1 meningococcal vaccine, propelling it to a familiar position: rivaling Pfizer.
The Trump administration’s effort to remake the federal workforce swept through US healthcare agencies on Friday, with wide ...
Renee Wegrzyn has been let go as the head of a federal agency that pursues ambitious ideas to accelerate biomedical ...
Bambusa Therapeutics raises $90M Series A for bispecific antibodies, led by RA Capital. Founded by BioNTech veterans, plans ...
Major drugmakers are planning to meet with President Donald Trump next week at the White House as part of the industry’s ...
David Schenkein will step down from Agios Phar­ma­ceu­ti­cals ’ board of di­rec­tors at the end of the month “to de­vote more ...
A series of actions by President Donald Trump's administration have provoked profound anxiety among academic labs that ...
Biogen is turning to Royalty Pharma for some cash in exchange for rights to a lupus program, the companies announced ...
West Pharmaceuticals stock drops 38% after ending glucose monitor contracts; CEO Eric Green says GLP-1 business will offset ...